MergerLinks Header Logo

Submit Deal

Submit Deal

Cover Image ALNYLAM
ALNYLAM

ALNYLAM

Summary

Alnylam Pharmaceuticals is an RNAi therapeutics company.

Deals Overview

Total Deals1
Valued Deals1
Total Value£ 1.60 B
Avg. Deal Size£ 1.60 B

Market Context

Sort

13 Apr 2020|United States|Pharmaceuticals
ALNYLAM
Blackstone Group

Target: ALNYLAM

Bidder: BLACKSTONE GROUP INC

7 Service Providers

3 Target | 4 Bidder

53 Dealmakers

23 Target | 31 Bidder

£ 1.60 B

Value

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy

Privacy PolicyTerms of ServiceContact UsCookie Preferences

All rights reserved. Copyright © 2025 Datasite